medigraphic.com
ISSN 1029-3043 (Electronic)

2021, Number 1

<< Back

Medicentro 2021; 25 (1)

Worsening of cardiorenal syndrome V in a patient with COVID-19

López RJ, Castro GN, Viera PI, Pena PN, Pérez RED

Language: Spanish
References: 15
Page: 148-160
PDF size: 506.63 Kb.


ABSTRACT

During the month of December 2019 in Wuhan, China, a number of patients with acute respiratory disease of unknown origin with unfavorable evolution were detected, identifying the SARS-CoV-2 coronavirus as the causal agent, better known for causing acute respiratory diseases, with interstitial and alveolar pneumonia, affecting multiple organs and systems (cardiovascular system, gastrointestinal tract, hematological system, nervous system and kidneys). Intervention with renal replacement therapies in grade III acute kidney injury, or in grade IV or V chronic kidney disease is frequent in these patients as part of the treatment established in the protocols. The evolution of a male patient with antecedents of type 2 diabetes mellitus, arterial hypertension, heart failure and chronic kidney disease was presented, aspects that triggered a cardiorenal syndrome V, which worsened with exposure to the SARS-CoV-2 virus; he was treated with conventional hemodialysis.


REFERENCES

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.

  2. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38.

  3. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun.;203(2):631-7.

  4. M. de Francisco A, Pérez Canga JL. Coronavirus y riñón. Actualización completa. Nefrología al día [internet]. España: Sociedad Española de Nefrología; 11 jun. 2020 [citado 13 dic. 2020]. Disponible en: https://www.nefrologiaaldia.org/es-articulo-coronavirus-rinon-actualizacion-completa-09-305

  5. Xu S, Fu L, Fei J, Xiang HX, Xiang Y, Tan ZX, et al. Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysis [preprint]. MedRxiv [internet]. 2020 [citado 13 dic. 2020]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.03.24.20042408v1

  6. Rivers E, Singer M. Mechanisms of sepsis induced organ dysfunction. Crit Care Med. 2007;35:2408-16.

  7. Zelniker TA, Braunwald E. Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Feb. 4;75(4):422-34.

  8. Cummings MJ, Baldwin MR, Abrams D. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763-70.

  9. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb. 24;323(13):1239-42.

  10. Ronco C, Navalesi P, Vincent JL. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Lancet Respir. 2019;8:240-1.

  11. Ronco C, McCullough P, Anker SD. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31(6):703-11.

  12. Yang J, Zheng Y, Gou X. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5.

  13. National Health Service - NHS. Clinical guide for acute kidney injury in hospitalised patients with COVID-19 outside the intensive care unit during the coronavirus pandemic [internet]. UK: NHS; 2020 Nov. [citado 6 dic. 2020]. Disponible en: https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/acute-kidney-injury-in-covid-outside-the-icu.pdf

  14. Ronco C, Ricci Z, Husain-Syed F. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients. Blood Purif. 2019;48:99-105.

  15. Koch B, Schult-Dietrich P, Büttner S, Dilmaghani B, Lohmann D, Baer PC, et al. Lectin affinity plasmapheresis for Middle East respiratory syndrome coronavirus and marburg virus glycoprotein elimination. Blood Purif. 2018;46:126-33.




2020     |     www.medigraphic.com